ReviewFrontiers in medicine2023
JAK inhibitors: A new dawn for oral therapies in inflammatory bowel diseases.
Claudia Herrera-deGuise et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
66 papers cite itlatest 60 shown
this paperpooled itcites it